Effect of primycin on growth-arrested cultures and cell integrity of Staphylococcus aureus

Péter Feiszt1,2, György Schneider2, Levente Emődy2,3

  • 11 PannonPharma Ltd. , Pécsvárad, Hungary.

Insights

Primycin effectively kills non-dividing Staphylococcus aureus without causing cell lysis, demonstrating a rare bactericidal characteristic. Its action targets the cell membrane, offering potential against resistant bacterial strains.

Area of Science:

  • Microbiology
  • Pharmacology

Background:

  • Bactericidal agents that kill non-dividing bacteria without lysis are rare and advantageous.
  • Primycin is a topical anti-staphylococcal agent with known efficacy against multiresistant strains, acting on the cell membrane.

Purpose of the Study:

  • To assess the bactericidal characteristics of primycin against non-dividing Staphylococcus aureus.
  • To elucidate the mechanism of primycin's action on bacterial cell membranes.

Main Methods:

  • Time-kill studies were performed on growth-arrested Staphylococcus aureus cultures.
  • Bacterial response to primycin was evaluated under conditions affecting metabolic activity, membrane potential, and temperature.
  • Optical density measurements and transmission electron microscopy were used to assess cell integrity.

Main Results:

  • Primycin maintained bactericidal activity against growth-arrested Staphylococcus aureus, though at a slower rate than against exponentially growing cells.
  • The bactericidal effect was independent of metabolic activity (stringent response, protein synthesis inhibition).
  • Disruption of membrane potential and membrane fluidity significantly influenced primycin's killing efficacy, while cell lysis was not observed.

Conclusions:

  • Primycin exhibits a favorable bactericidal effect against non-dividing bacteria without causing lysis.
  • The mechanism of action involves disruption of the bacterial cell membrane potential and is influenced by membrane fluidity.
  • Primycin's membrane-targeting action warrants further investigation for treating infections caused by resistant bacteria.